Compositions and methods for therapy and diagnosis of cancer
    15.
    发明授权
    Compositions and methods for therapy and diagnosis of cancer 失效
    癌症治疗和诊断的组成和方法

    公开(公告)号:US08088913B2

    公开(公告)日:2012-01-03

    申请号:US12096216

    申请日:2006-12-07

    摘要: The present invention is directed to siRNA molecules which specifically target and cause RNAi-induced degradation of mRNA from TPTE genes, so that the protein product of the TPTE gene is not produced or is produced in reduced amounts. The siRNA compounds and compositions of the invention are useful for treating diseases which require inhibition of TPTE expression for their treatment, in particular cancer pathologies. The present invention also includes methods which make possible to assess and/or prognose the metastatic behavior of a cancer disease and/or the occurrence of a relapse of cancer.

    摘要翻译: 本发明涉及特异性靶向并引起来自TPTE基因的mRNA的RNAi诱导的降解的siRNA分子,使得TPTE基因的蛋白质产物不产生或以减少的量产生。 本发明的siRNA化合物和组合物可用于治疗需要抑制TPTE表达以治疗,特别是癌症病症的疾病。 本发明还包括使得有可能评估和/或预测癌症疾病的转移行为和/或癌症复发的方法。

    COMPOSITIONS AND METHODS FOR THERAPY AND DIAGNOSIS OF CANCER
    17.
    发明申请
    COMPOSITIONS AND METHODS FOR THERAPY AND DIAGNOSIS OF CANCER 失效
    癌症治疗和诊断的组成和方法

    公开(公告)号:US20090221674A1

    公开(公告)日:2009-09-03

    申请号:US12096216

    申请日:2006-12-07

    摘要: The present invention is directed to siRNA molecules which specifically target and cause RNAi-induced degradation of mRNA from TPTE genes, so that the protein product of the TPTE gene is not produced or is produced in reduced amounts. The siRNA compounds and compositions of the invention are useful for treating diseases which require inhibition of TPTE expression for their treatment, in particular cancer pathologies. The present invention also includes methods which make possible to assess and/or prognose the metastatic behaviour of a cancer disease and/or the occurrence of a relapse of cancer.

    摘要翻译: 本发明涉及特异性靶向并引起来自TPTE基因的mRNA的RNAi诱导的降解的siRNA分子,使得TPTE基因的蛋白质产物不被产生或以减少的量产生。 本发明的siRNA化合物和组合物可用于治疗需要抑制TPTE表达以治疗,特别是癌症病症的疾病。 本发明还包括使得有可能评估和/或预测癌症疾病的转移行为和/或癌症复发的方法。